Mirella Mourad
Columbia University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mirella Mourad as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:25 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05772156 · Prophylactic Methylergonovine for Twin CesareanColumbia University · completed · Twin; Complicating Pregnancy, Postpartum Hemorrhage · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:25 UTC. The ranking covers the 200 most relevant of 33 PubMed records, and a shared surname and initials can bring in a namesake. All 33 on PubMed
- Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.Clin Chem · 2001157 citationsRCR 5.7
- Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids.Transplantation · 200598 citationsRCR 2.9
- Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation.Clin Chem · 200194 citationsRCR 3.6
- Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients.Ther Drug Monit · 201481 citationsRCR 3.6
- Oxygenated End-Hypothermic Machine Perfusion in Expanded Criteria Donor Kidney Transplant: A Randomized Clinical Trial.JAMA Surg · 202166 citationsRCR 5.4
- Four-year experience with tacrolimus once-daily prolonged release in patients from phase II conversion and de novo kidney, liver, and heart studies.Clin Transplant · 201155 citationsRCR 2.5
- 43 citationsRCR 2.1
- Simultaneous pancreas-kidney transplantation in a large multicenter study: surgical complications.Transplant Proc · 200538 citationsRCR 1.7
- A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation.J Clin Pharmacol · 201238 citationsRCR 1.8
- Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.J Hosp Med · 201736 citationsRCR 2.6